Applied Therapeutics Shares Plunge as Cycle Group Announces Deep-Discount Buyout

Applied Therapeutics’ stock drops 33% premarket after Cycle Group agrees to acquire the company at a steep discount, with potential future CVR payouts and a closing expected in early 2026.